baber/WOPTO huggingface dataset:
Patent NZ-561490-A (NZ)
Title: Mechanical locking system for floor panels and a method to disconnect floor panels
Inventor: PERVAN DARKO
IPC: E04F15/04
Filed: 2006-01-10
Abstract: A flooring system comprising a number of floor panels 1, 1' mechanically connected to each other along a pair of adjacent edges, with each panel having a tongue 10 along one edge and a groove 9 along the opposite edge formed in one piece with the panel 1, 1'. The tongue 10 and groove 9 arrangement mechanically locks together adjacent joint edges of the panels at right angles to the principal plane of the panels with the upper parts of the joint edges in contact with each other. The panels have another locking element 15 placed on the tongue side of the floor panel behind the leading edge of the tongue 10. This second locking element 15 is formed of a separate material, connected to the locking groove 14, flexible and resilient. When the adjacent panels 1, 1' are moved towards each other, a part 32 of the second locking element 15 will be displaced vertically until the panels are connected with the first tongue 10 and groove 9 locking system. The displaced portion 32 of the second locking element 15 will then engage a groove 20 in the other panel.
Patent NZ-565200-A (NZ)
Title: Device for locking telescoping shafts by friction fit between spring and shaft
Inventor: MOORE SIMON GARRY
IPC: A63B53/16
Filed: 2008-01-17
Abstract: An adjustable mechanism 1 for connecting a first shaft 2 with a hollow second shaft 4 comprises a spring 6 attached at one end of the second shaft 4. The spring 6 has an inner diameter similar to the outer diameter of the first shaft 3. The spring 6 ends in a solid ring 7. By pushing the ring 7 back towards the second shaft 4 the inner diameter of the spring 6 is increased to be greater than the outer diameter of the first shaft 2. This allows insertion of the first shaft 2 into the spring 6 and the second shaft 4. The ring 7 is then released to allow the spring 7 to return to its original dimensions. Since the first shaft 2 is now inside the spring 6 and the inner diameter of the spring 6 is similar to the outer diameter of the first shaft 2, the spring 6 will now grip the outer surface of the first shaft 2. The mechanism 1 further comprises an anti rotation mechanism that restricts relative rotation of the first and second shafts when the shafts are in position. The anti-rotation mechanism is selected from: a second spring anchored to an end of the first shaft 2; a non-circular section of the first and second shafts, and a protrusion on one shaft and a corresponding indentation on the other shaft.
Patent NZ-586228-A (NZ)
Title: Treatment of inflammatory illnesses with ace2
Inventor: LOIBNER HANS
IPC: A61K38/48
Filed: 2008-12-18
Abstract: Disclosed is the use of ACE2, for the production of a pharmaceutical composition for the therapeutic treatment or prevention of an inflammation selected from rheumatitis, sepsis, arthritis, rheumatoid systemic lupus erythematosus, scleroderma, an antiglomerular basal membrane disease, autoimmune diseases of the nervous system, systemic lupus erythematosus, Addison's disease, an antiphospholipid syndrome, an IgA glomerulonephritis, a Goodpasture syndrome, a Lambert-Eaton myasthenic syndrome, idiopathic purpura, an autoimmune thyroiditis, a rheumatoid arthritis, an insulin-dependent diabetes mellitus, a pemphigus, an autoimmune hemolytic anemia, a dermatitis herpetiformis During, a membranous glomerulonephritis, a Graves disease, a sympathetic ophthalmia, autoimmune polyendocrinopathies, multiple sclerosis and/or Reiter's disease.
Patent NZ-586316-A (NZ)
Title: Counter-pressure filtration of proteins
Inventor: NIKOLIC NEBOJSA
IPC: A61K9/08
Filed: 2008-12-22
Abstract: Disclosed is a method of filtering a liquid protein mixture, the method comprising: providing a liquid mixture at a first pressure (Pi), the liquid mixture comprising a carrier liquid, a protein at a first concentration (Ci) relative to the carrier liquid, and a dispersed contaminant; passing the liquid mixture through a filter to form a filtrate at a second pressure (P2), the filtrate comprising the carrier liquid and the protein at a second concentration (C2) relative to the carrier liquid, wherein the filter is sized to remove at least a portion of the dispersed contaminant from the liquid mixture; and applying a counter pressure to the filtrate to ensure that a pressure differential between the first and second pressures (P1 - P2) is not more than about 300 mbar.
Patent NZ-587929-A (NZ)
Title: Chemokine receptor modulators
Inventor: CLARK MICHAEL P
IPC: C07D403/14
Filed: 2009-03-30
Abstract: Disclosed are substituted tetrahydroquinolin-8-amine derivatives of Formula (I) for the treatment of a disorder associated with chemokine receptor activation. Specific examples of compounds of Formula (I) include: N-((9H-pyrido[3,4-b]indol-1-yl)methyl)-N-methyl-5,6,7,8-tetrahydroquinolin-8-amine tetrahydrochloride N-((1H-indol-7-yl)methyl)-N-methyl-S,6,7,8-tetrahydroquinolin-8-amine N-(4-aminobutyl)-N-((3-phenyl-3H-1,2,3-triazol-4-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine tetrahydrochloride, and N-methyl-N-((1-(2-((pyridin-2-ylmethylamino)methyl)phenyl)-1H-1,2,3-triazol-4-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine. Compounds of Formula (I) are useful for treating a disorder selected from human immunodeficiency virus (HIV) infection, pestivirus infection and cancer.
Patent NZ-588052-A (NZ)
Title: Catalytic pyrolysis of solid biomass and related biofuels, aromatic, and olefin compounds
Inventor: CHENG YU-TING
IPC: C10G11/18
Filed: 2009-03-03
Abstract: ABSTRACT - 588052 The disclosure relates to a method for producing one or more fluid hydrocarbon products from a solid hydrocarbonaceous material comprising the steps of: providing a solid catalyst in a fluidized bed reactor, the solid catalyst comprising zeolite, WOx/ZrO2, aluminum phosphate, and/or a metal and/or oxide of nickel, platinum, vanadium, palladium, manganese, cobalt, zinc, copper, chromium and/or gallium; (b) feeding the solid hydrocarbonaceous material to the fluidized bed reactor at a massnormalized space velocity of between about 0.01 hour-1 and about 10 hour-1; (c) pyrolyzing within the fluidized bed reactor at least a portion of the hydrocarbonaceous material under reaction conditions sufficient to produce one or more pyrolysis products; and (d) catalytically reacting at least a portion of the one or more pyrolysis products using the solid catalyst under reaction conditions sufficient to produce the one or more fluid hydrocarbon products; wherein the residence time of the hydrocarbonaceous material in the fluidized bed reactor is at least about 10 seconds, the residence time being calculated by dividing the volume of the reactor with the volumetric flow rate of the hydrocarbonaceous material and fluid hydrocarbon product exiting the reactor.
Patent NZ-590567-A (NZ)
Title: A genetic marker test for brachyspina ( based on snp on bovine chromosome 21) and fertility in cattle
Inventor: GEORGES MICHEL
IPC: C12Q1/68
Filed: 2009-07-27
Abstract: Discloses a method for determining whether a bovine (Bos taurus) is affected by, or carrier of, the genetic defect that causes brachyspina by analysing its genomic DNA or RNA, the method comprising the steps of: a) obtaining a sample of biological material containing 5 said genomic DNA from the bovine b) extracting the nucleic acid from said sample c) genotyping the nucleic acid for SNPs located in the interval between nucleotide positions 20156961 and 22499122 on bovine chromosome 21 d) ascertaining whether said animal carries the brachyspina-risk haplotype Further disclosed are uses of the method perform marker assisted selection or genomic selection for increased fertility in said bovine species.
Patent NZ-592492-A (NZ)
Title: Electrodes for use in bacterial fuel cells and bacterial electrolysis cells and bacterial fuel cells and bacterial electrolysis cells employing such electrodes
Inventor: LEVY EYTAN BARUCH
IPC: B05D5/12
Filed: 2009-11-01
Abstract: 592492 A bacterial fuel cell including a plurality of anodes (100, A) and a plurality of cathodes (102, C) in liquid communication with a liquid (104) to be purified. The plurality of anodes and the plurality of cathodes each include a metal electrical conductor (110) arranged to be electrically coupled across a load in an electrical circuit and an electrically conductive coating (112) at least between the metal electrical conductor and the liquid to be purified. The electrically conductive coating is operative to mutually seal the liquid and the electrical conductor from each other. At least one surface (116) is adapted for biofilm growth on a surface thereof.
Patent NZ-593207-A (NZ)
Title: Isolated renal cells and uses thereof
Inventor: PRESNELL SHARON
IPC: A61K35/12
Filed: 2009-11-12
Abstract: Disclosed is an admixture of human renal cells comprising a first cell population, B2, comprising an isolated, enriched population of tubular cells having a density between 1.045 g/mL and 1.052 g/mL, and a second cell population comprising erythropoietin (EPO)-producing cells, glomerular cells and vascular cells, wherein the admixture does not include a B1 cell population comprising large granular cells of the collecting duct and tubular system having a density of < 1.045 g/ml, and/or a B5 cell population comprising debris and small cells of low granularity and viability with a density > 1.091 g/ml.
Patent NZ-594057-A (NZ)
Title: Processes for preparing jak inhibitors and related intermediate compounds
Inventor: WANG HAISHENG
IPC: C07D231/16
Filed: 2010-01-14
Abstract: IP No. 594057 The present disclosure is related to processes for preparing chiral substituted pyrazolyl pyrrolo[2,3-di]pyrimidines of Formula III, and related synthetic intermediate compounds. The chiral substituted pyrazolyl pyrrolo[2,3-d]pyrimidines are useful as inhibitors of the Janus Kinase family of protein tyrosine kinases (JAKs) for treatment of inflammatory diseases, myeloproliferative disorders, and other diseases.
Patent NZ-594403-A (NZ)
Title: Amorphous salt of a macrocyclic inhibitor of hcv
Inventor: VAN REMOORTERE PETER JOZEF MARIA
IPC: A61K31/395
Filed: 2010-02-26
Abstract: 594403 Disclosed herein is a sodium salt of the macrocyclic inhibitor of HCV of formula (I) (TMC435) in solid amorphous form as well as processes for manufacturing this salt. Additionally disclosed is the use thereof in the treatment of HCV.
Patent NZ-595684-A (NZ)
Title: Urine markers for detection of bladder cancer
Inventor: GUILFORD PARRY JOHN
IPC: C07H21/04
Filed: 2005-07-22
Abstract: 595684 Disclosed is a method for detecting bladder cancer in a subject, comprising detecting the accumulation of a urinary bladder tumor marker ("UBTM") in the urine, said accumulation in said subject greater than about 1.2 times the accumulation of said UBTM in urine from a group of normal subjects not having malignant bladder cancer, wherein the UBTM is Insulin like growth factor binding protein 5 (IGFBP5).
Patent NZ-596981-A (NZ)
Title: Compositions and methods for the treatment of tumor of hematopoietic origin
Inventor: DESAUVAGE FREDERIC J
IPC: C07K16/30
Filed: 2004-11-16
Abstract: 596981 Disclosed is the use of an antibody that specifically binds a protein having at least 80% amino acid sequence identity to: (a) a polypeptide having the amino acid sequence shown in SEQ ID NO: 51 in Figures 51A and B with or without its associated signal peptide; (b) a polypeptide encoded by the nucleotide sequence shown in SEQ ID NO: 50 in Figures 50A and B, or (c) a polypeptide encoded by the full-length coding region of the nucleotide sequence shown in SEQ ID NO: 50 in Figures 50A and B, in the manufacture of a medicament for inhibiting unwanted cell growth by a cell selected from the group consisting of a diffuse large cell lymphoma cell, a follicular lymphoma cell, and a mantle cell lymphoma cell, wherein the medicament is formulated for contacting said cell with an antibody that binds to said protein thereby causing an inhibition of growth of said cell, and wherein said antibody is conjugated to monomethylauristatin (MMAE).
Patent NZ-597773-A (NZ)
Title: Raccoon poxvirus expressing rabies glycoproteins
Inventor: WU STEPHEN QITU
IPC: A61K39/275
Filed: 2008-05-28
Abstract: NZ 597773 Disclosed is a recombinant raccoon poxvirus vector (rRCNV) comprising two or more exogenous nucleic acid molecules, each encoding at least one rabies virus glycoprotein, wherein at least one of the nucleic acid molecules is inserted into each of the hemagglutinin (ha) and thymidine kinase (tk) loci, and wherein a source of rabies virus glycoprotein is selected from a Challenge Virus Standard rabies strain and a Pasteur-Paris rabies strain, wherein the nucleic acid molecule encoding the glycoprotein that is inserted at the thymidine kinase locus of the raccoon poxvirus genome is from the Challenge Virus Standard rabies strain, and wherein the nucleic acid molecule encoding the glycoprotein that is inserted at the hemagglutinin locus of the raccoon poxvirus genome is from the Pasteur-Paris rabies strain.
Patent NZ-599615-A (NZ)
Title: Transformer structure for smart load balancing
Inventor: NIELSEN MATTHEW CHRISTIAN
IPC: H01F38/00
Filed: 2012-04-26
Abstract: Disclosed is a system for balancing load in an electricity distribution network. The system is comprised of a transformer having a plurality of integrated sensors (35) and a control system (30) in electrical communication with the plurality of sensors (35). The control system (30) is configured to estimate or determine the state of health of the transformer in response to signals generated by the plurality of sensors (35). The control system (30) is further configured to compare the state of transformer health to a load request received from one or more loads to determine if the transformer can support the load request. Based on this comparison, the control system (30) acknowledges or agrees to provide electrical power to meet the load request or it requests agreement from the one or more loads to modify the load request.
Patent NZ-603347-A (NZ)
Title: System for improved hemodynamic detection of circulatory anomalies
Inventor: EGGERS ANDREW R
IPC: A61B5/02
Filed: 2011-04-06
Abstract: Disclosed is a system for detecting the presence of a right-to-left pulmonary shunt in a patient. The system includes an indicator delivery system having an outlet located in a vein of the patient in blood flow communication with the right side of the heart and actuable to deliver a fluorescing biocompatible indicator into the vein such that the indicator will arrive at the right side of the heart within an anticipated transit time. The system also includes at least one optical sensor comprising a plurality of photodiode emitter energisable to generate light at the excitation radiation wavelength of the fluorescing indicator and a like number of photodetectors located in the housing of the sensor to detect light emitted from the fluorescing indicator at a second wavelength. The photodetectors are positioned on the opposite side of a tissue-receiving space from the photodiode emitters. The system also includes a monitor/controller for cueing actuation of the indicator delivery system, commence timing of the anticipated indicator transit time, display indicator dilation curves and, when a shunt is detected, to calculate and shunt conductance ratio from indicator dilution curves.
Patent NZ-607485-A (NZ)
Title: Combinations of beta - 3 adrenergic receptor agonists and muscarinic receptor antagonists for treating overactive bladder
Inventor: CALTABIANO STEPHEN
IPC: A61P13/10
Filed: 2011-08-02
Abstract: The disclosure relates to pharmaceutical combinations comprising (i) a therapeutically effective amount of a beta-3 adrenergic receptor agonist selected from the group consisting of solabegron and pharmaceutically acceptable salts thereof, pharmaceutically acceptable solvates thereof and pharmaceutically acceptable salts thereof solvated with pharmaceutically acceptable solvents thereof; and (ii) a therapeutically effective amount, or a sub-therapeutically effective amount of a muscarinic receptor antagonist selected from the group consisting of tolterodine, oxybutynin, trospium, solifenacin, darifenacin, propiverine, fesoterodine, pharmaceutically acceptable salts thereof, a pharmaceutically acceptable solvates thereof, and pharmaceutically acceptable salt solvated with pharmaceutically acceptable solvent thereof, said combination being useful for relieving one or more symptoms associated with overactive bladder (OAB) in a synergistic manner, versus the individual components (i) and (ii). Preferred combinations include solabegron and oxybutynin. These pharmaceutical combinations are suitable for the treatment of one or more symptoms associated with overactive bladder, for example, frequency of urgency, nocturia, and urinary incontinence.
Patent NZ-608218-A (NZ)
Title: Nasal spray device
Inventor: WALSH DECLAN
IPC: B65D83/54
Filed: 2011-10-12
Abstract: A nasal spray device (1) for the delivery of a pharmaceutical formulation to the nasal cavity is disclosed. The device (1) comprises a pressurised aerosol canister (4) with a metering valve (6) having a valve stem (8). The device further comprises an actuator (2) displaceable relative to the canister(4) including a stem block (11) to receive the valve stem and a sump (15) extending below the valve stem receptacle. The stem block further defines a discharge orifice (19) for the pharmaceutical formulation and a transfer channel (13) through which the dose is able to pass from the sump (15) to the discharge orifice (19). The actuator (2) further comprises a nose piece(12) for the aerosol plume. The device is adapted to produce an aerosol plume with a spray force value no greater than 40 mN at a distance of 30 mm from the discharge orifice (12).
Patent NZ-615230-A (NZ)
Title: A method for treatment of waste water
Inventor: HARDING ALAN ROBERT
IPC: C02F1/66
Filed: 2012-09-06
Abstract: The disclosure relates to a method of treating waste water containing suspended organic material, the method including the steps of: (a) mixing agriculturally beneficial acids selected from phosphoric acid, sulphuric acid or nitric acid with the waste water, wherein the acid reduces the pH of the waste water to 1 to 4; (b) holding the waste water and acid mixture for a period of time between 12 and 48 hours to allow particulate matter to precipitate out of the mixture; (c) flocculating the mixture with an alkali containing material, wherein the alkali containing material includes calcium and/or magnesium containing material selected from lime, hydrated lime, agricultural lime, calcium hydroxide, magnesium oxide, dolomite, serpentine or calcium bentonite, and wherein the alkali containing material increases the pH to between 10 and 12; and (d) collecting the resulting flocculent of step (c) and applying it to pasture or soil as a fertiliser and/or soil modifier.
Patent NZ-617293-A (NZ)
Title: Methods in base stations, base stations, computer programs and computer program products
Inventor: DIMOU KONSTANTINOS
IPC: H04W36/04
Filed: 2011-05-12
Abstract: The invention relates to a method in a first base station (10) having a first coverage area (100) at least partly overlapping with a second coverage area (400) of a second base station (40), the first base station (10) operating within a first transmission power range and the second base station (40) operating within a second transmission power range. The method comprises determining radio link quality of a user equipment UEl connected to the first base station (10) and being located in an adjustable extended coverage range (410) of the second base station (40). Requesting from the second base station (40) interference related measurements for unused physical channels or for physical channels at least partially overlapping with physical channels used by the user equipment UEl connected to the first base station (10) and having the radio link quality falling below a threshold value. Deciding for the user equipment UEl connected to the first base station (10), based on the interference related measurements, if a handover to the second base station (40) should be performed.
Patent NZ-624330-A (NZ)
Title: Method and apparatus for gripping
Inventor: WALMSLEY OWEN
IPC: F16L25/06
Filed: 2012-10-04
Abstract: A method and apparatus for gripping, especially a method and apparatus for gripping elongate pipes, bars, beams, etc., is disclosed. The apparatus (10) comprises a body (12), the body having an inner cavity (20) for receiving a piece (P) to be gripped. The inner cavity (20) has a sidewall, a recess (18) provided around at least a portion of the sidewall and a clamping member (22) within the recess (18). The recess is adjustable to compress the member (22) so it is urged out of the recess and into the inner cavity (see Fig. 3). The clamping member comprises multiple separate pieces.
Patent NZ-625798-A (NZ)
Title: Processes for the manufacture of a pharmaceutically active agent
Inventor: ROCK MICHAEL HAROLD
IPC: C07D209/16
Filed: 2010-12-20
Abstract: Disclosed herein is a process for the preparation of N-(2-(6-fluoro-1H-indol-3-yl)ethyl(2,2,3,3-tetrafluoropropoxy)benzylamine and pharmaceutically acceptable salts thereof. The disclosure particularly relates to a process for the preparation of the compound of formula (IV) comprising the steps of: (a) mixing (6-fluoro-1H-indol-3-yl)acetonitrile, 25 % NH3 in water and a transition metal catalyst (such as RaNi which is an activated Nickel Catalyst) in an alcoholic solvent such as methanol; and (b) hydrogenating the mixture with H2. Also disclosed is a process for the preparation of a compound of formula (II), which comprises the steps of: (a) mixing a solution of diethoxymethane, water and formic acid; (b) adding the solution of step (a) to a mixture of 6-fluoroindole, methylamine and acetic acid; and (c) adding an aqueous basic solution (such as sodium hydroxide NaOH).
Patent NZ-626490-A (NZ)
Title: Improved closure for beverage container
Inventor: JUSTIN ARMISTEAD
IPC: B65D47/24
Filed: 2014-06-19
Abstract: A closure means (1) for a container for beverages, includes a main body portion (2) adapted to be releasably affixed to a neck of said container. The main body portion (3) having an elongate member and a plunger means (3). The elongate member extends substantially normally from an upper surface (7) thereof and allows selective access to the contents of a container. The plunger means (3) adapted to be readily and selectively movable relative to the main body portion (2) and said elongate member between respective end positions which correspond to a closed and a dispensing configuration for the closure means (1). The elongate member has a groove on the external surface for accepting a sealing means, such as an o-ring, to form a seal between the plunger and the elongate member.